ICCCS Web Header 6944x611

Share

    


In This Section

Dermatologic Toxicities

Supportive Care Strategies for Dermatologic Toxicities

Acute and long-term dermatologic adverse events are experienced by both patients and survivors alike. Despite documentation of more than 50 distinct dermatologic toxicities in association with at least 30 anti-cancer agents, dermatologic adverse events are often underreported or overlooked. Supportive oncologic dermatology bridges gaps in communication by fostering collaboration among oncologists, dermatologists, nurses, and other supporting professionals to ease the burden of dermatologic toxicities on patients and improve treatment adherence and patient outcomes.

The Association of Cancer Care Centers (ACCC) provides resources to refine strategies for assessing, preventing, and managing dermatologic toxicities, emphasizing timely evaluation, clinical advancements, and overall care management to improve patient outcomes.

Featured Resources

Preventing and Managing Common Dermatologic Toxicities: A Guide for Clinicians

085_DermTox_TipSheet_ScreenShot 

Dermatologic toxicities are adverse events (AEs) that involve the skin, hair, or nails and are associated with antineoplastic treatment. These can cause significant discomfort, emotional distress, and, in severe cases, serious harm or treatment disruption. This guide reviews common dermatologic toxicities associated with cancer treatments, opportunities for prevention, and management.
Read Now

CANCER BUZZ Podcast

Supporting Skin Health in Patients with Breast Cancer
[Ep. 181]

In this episode of CANCER BUZZ, Allison Gordon, MD, discusses the dermatologic toxicities associated with breast cancer treatment, explores preventive measures that oncologists can implement early in the treatment course and offers alternative resources when an oncodermatologist referral is not feasible.
Listen Now

A Practice Within a Practice: Integrating Oncodermatology into Comprehensive Cancer Care
[Video Podcast] Ep 49

Novel cancer therapies have emerged over the past 10-15 years with high rates of cutaneous side effects, increasing the need for oncodermatology specialists. Dr. Meghan Heberton, who built the oncodermatology program at UT Southwestern Medical Center, discusses the management of therapeutic complications and importance of multidisciplinary collaboration, the need for holistic care plans, and the impact of access issues for cancer patients seeking dermatologic expertise.
Watch the Video Podcast

Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care
[Video Podcast] Ep 53

In this episode, CANCER BUZZ speaks with Dr. Julie Ryan Wolf and Dr. CJG (Corina) van den Hurk from the Oncodermatology Study Group at MASCC. They discuss common toxicities like radiation dermatitis, hair loss, and EGFR-inhibitor-related nail changes, along with strategies to enhance early intervention and collaboration among providers to improve patient outcomes.

 

From the ACCC Buzz Blog

A Patient Journey Focus on Oncodermatology

Skin, hair, and nail toxicities from cancer treatment can severely impact quality of life to the point where patients may discontinue treatment. Access to dedicated oncodermatology services is essential for quality patient care. Learn from Dr Jennifer N. Choi of Robert H. Lurie Comprehensive Cancer Center and survivor Lawrence Stallings on how providing more holistic care through oncodermatology may address these unmet needs.
Read Now

For more information on this project, please contact the ACCC Provider Education department.

Our Partners

MASCC-350x188
Oncodermatology-Society-350x240
SOCS-350x350

Our Sponsor

astrazeneca-200x80 Johnson-&-Johnson-460x80This project is made possible by support from AstraZeneca and Johnson & Johnson.